Skip to main content

New Products

  • Medbox buys stake in drug-vending company, forms jointly controlled corporation

    NEW YORK — Pharmaceutical vending machine maker Medbox has bought a 50% stake in a Michigan-based company that has developed an automated medicine dispensing machine, Medbox said Friday.

    The $5.15 million deal with MedVend includes a $300,000 capital infusion and additional loans if needed for operating expenses into a jointly controlled new corporation that will also be called MedVend.

  • FDA approves Par generic obsessive compulsive disorder drug

    WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a drug for obsessive compulsive disorder made by Par Pharmaceutical Cos., the drug maker said Thursday.

    Par announced the approval and shipment of fluvoxamine maleate extended-release capsules in the 100-mg and 150-mg strengths. The drug is a generic version of Jazz Pharmaceuticals' Luvox CR.

  • Mylan can launch generic diabetes drug in August

    PITTSBURGH — Mylan has settled a patent-infringement lawsuit filed by Shionogi over its generic version of a drug for diabetes, Mylan said.

    The generic drug maker said that under the agreement, it can launch a generic version of Shionogi's Fortamet (metformin hydrochloride) extended-release tablets in the 500-mg and 1,000-mg strengths on Aug. 1.

    Metformin hydrochloride extended-release tablets in those two strengths had sales of about $125 million during the 12-month period that ended in September, according to IMS Health.

     

  • SoloHealth named to Georgia’s list of Top 10 Innovative Technology Companies

    ATLANTA — SoloHealth on Thursday announced it has been selected as one of the Technology Association of Georgia’s Top 10 Innovative Technology Companies. SoloHealth was recognized for its FDA-approved health and wellness kiosk, the SoloHealth Station.

    "The Top 10 awards are given to an elite group of companies whose products and solutions are not only changing their respective industries, they also are putting Georgia on the map as a state where technology innovation can thrive," stated Tino Mantella, president & CEO of TAG. 

  • Nestlé reveals new candy offerings in time to stock Easter baskets

    GLENDALE, Calif. — Just in time for Easter celebrations, Nestlé USA Confections and Snacks has unveiled a handful of new offerings available in retail stores nationwide.

    The collection's highlights for spring include:

  • FDA to review experimental opioid drug

    BEDMINSTER, N.J. — The Food and Drug Administration will decide in late August whether to approve an experimental opioid painkiller made by QRxPharma, the drug maker said Thursday.

    Australia-based QRxPharma is seeking approval for Moxduo (morphine and oxycodone), and the FDA plans to decide whether to approve the drug on Aug. 26.

  • Tabasco jelly beans fire up candy aisle

    FAIRFIELD, Calif. — Jelly Belly Candy Company has introduced new Jelly Belly Tabasco jelly bean bottles to candy shelves, the company announced today.

    Jelly Belly Tabasco jelly beans mimic the traditional Tabasco brand bottle and are filled with the newest Jelly Belly jelly beans spiced with genuine Tabasco brand seasonings.

  • Energems chocolate energy supplements hit store shelves

    DEERFIELD BEACH, Fla. — Energems, a new "energy bite" made with real milk chocolate is hitting store shelves this spring, the company announced today. Charlotte, N.C., has been selected as the official city to unveil the new energy supplement, with expansion to other retail locations coming soon.

X
This ad will auto-close in 10 seconds